Coincidentally, dysregulation of MSC-AS1 expression was found to promote tumor progression in glioma and osteosarcoma through the PI3K-Akt pathway [32,33], which may further support the important role of MSC-AS1/PI3K-Akt pathway in DV to a certain extent. Here, AKT1 is linked to central nervous system cancer.